Last reviewed · How we verify
NCT04504422
tDCS for Dual-task Performance in Patients With PD
NA trial testing transcranial Direct Current Stimulation (tDCS) in Parkinson Disease in 24 participants. Completed in 13 February 2024.
13 February 2024
Quick facts
| Lead sponsor | Seoul National University Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 24 |
| Start date | 5 November 2020 |
| Primary completion | 13 February 2024 |
| Estimated completion | 13 February 2024 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- transcranial Direct Current Stimulation (tDCS)
Conditions studied
- Parkinson Disease — all drugs for Parkinson Disease →
Sponsor
Seoul National University Hospital
Who can join
19 and older, any sex, with Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to investigate the optimal stimulation location of transcranial direct current stimulation to improve the dual-task performance in patients with Parkinson's disease.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Comparison of stimulation sites enhancing dual-task performance using transcranial direct current stimulation in Parkinson's disease.
Yun SJ, Hyun SE, Lee WH, Oh BM, et al · · 2025 · cited 2× · PMID 39827184 · DOI 10.1038/s41531-025-00869-5
Verify or expand the search:
- PubMed search for NCT04504422
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of transcranial Direct Current Stimulation (tDCS)
Trials testing the same drug.
- NCT04206215 — Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome · NA · recruiting
- NCT04777149 — Random Noise Stimulation to Enhance Cortical Drive & Improve Hand Function · NA · completed
- NCT04978142 — MaST: MEG and Brain Stimulation in Tinnitus · NA · completed
- NCT03813355 — Evaluation of tDCS Efficacy in Enduring Anorexia Nervosa · NA · terminated
- NCT04075890 — Arbitration Between Habitual and Goal-directed Behavior in Obsessive-compulsive Disorder: Circuit Dynamics and Effects o · NA · completed
Other recruiting trials for Parkinson Disease
Currently open trials in the same condition.
- NCT07399496 — Accelerated TMS for Apathy in PD · NA · recruiting
- NCT07371338 — Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients · Phase 1 · recruiting
- NCT07442370 — The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients · NA · recruiting
- NCT06848205 — Percept Transitions in FOG and PD · NA · recruiting
- NCT07432958 — A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (P · Phase 2 · recruiting
Other Seoul National University Hospital trials
Trials by the same sponsor.
- NCT07262944 — EOI Block in Otoplasty With Rib Cartilage Graft · NA · recruiting
- NCT07464210 — Nemtabrutinib, Bortezomib, and Rituximab for WM · Phase 2 · not yet recruiting
- NCT07550803 — Effect of Intraoperative Dexamethasone on Early Postoperative Sleep Quality in Patients Undergoing Nasal Surgery · NA · not yet recruiting
- NCT07522138 — Home-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study · NA · not yet recruiting
- NCT07476651 — Scout Dose of Resin Microspheres · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04504422 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Seoul National University Hospital
- Last refreshed: 20 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04504422.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing